Synergy Health Receives “Buy” Rating from Investec (SIE)
Synergy Health (LON:SIE)‘s stock had its “buy” rating reiterated by research analysts at Investec in a report released on Friday, AnalystRatingsNetwork reports. They currently have a GBX 1,400 ($23.07) price target on the stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Synergy Health in a research note to investors on Tuesday, December 17th. They now have a GBX 1,300 ($21.42) price target on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Synergy Health in a research note to investors on Thursday, November 14th. They now have a GBX 1,100 ($18.13) price target on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of GBX 1,175.50 ($19.37).
Synergy Health (LON:SIE) traded up 0.15% on Friday, hitting GBX 100.2525. The stock had a trading volume of 156,990 shares. Synergy Health has a 52 week low of GBX 75.691 and a 52 week high of GBX 88.20. The stock’s 50-day moving average is GBX 9744.65 and its 200-day moving average is GBX 8988.99. The company’s market cap is £84.513 billion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.